Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
暂无分享,去创建一个
M. Mack | A. Kirtane | L. Svensson | M. Leon | Craig R. Smith | D. Cohen | P. Généreux | Thomas McAndrew | Ke Xu | R. Makkar | S. Kodali | Mathew R. Williams | T. McAndrew | D. Cohen | D. Cohen
[1] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[2] J. Maessen,et al. Blood Transfusion and the Risk of Acute Kidney Injury After Transcatheter Aortic Valve Implantation , 2012, Circulation. Cardiovascular interventions.
[3] J. Bavaria,et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. , 2012, Journal of the American College of Cardiology.
[4] P. Serruys,et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. , 2012, American heart journal.
[5] Susheel Kodali,et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. , 2012, Journal of the American College of Cardiology.
[6] D. Capodanno,et al. Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis. , 2012, The American journal of cardiology.
[7] M. Deutsch,et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. , 2012, Journal of the American College of Cardiology.
[8] J. Leipsic,et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. , 2012, Journal of the American College of Cardiology.
[9] P. Jüni,et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. , 2011, Journal of the American College of Cardiology.
[10] Stuart J Pocock,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.
[11] P. Serruys,et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[12] Pascal Vranckx,et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.
[13] S. Pocock,et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.
[14] P. Serruys,et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.
[15] Fabian Nietlispach,et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.
[16] Chris A Rogers,et al. Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.
[17] Lukas Altwegg,et al. Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.
[18] Thomas Walther,et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.
[19] Liang Li,et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting* , 2006, Critical care medicine.
[20] Assaf Bash,et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.
[21] Pascal Vranckx,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[22] P. Serruys,et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[23] Y. Castier,et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.